Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Adipose tissue (AT) general comments
- In vitro methods
- In vivo methods
- AT regulation
- AT components
- Storage mobilization overview
- Lipoprotein lipase (LPL) action
- LPL in various conditions and fat deposits
- Transcapillary flux of fatty acids ( FA)
- Theoretical fate of fatty acids in a cell
- Fat cell fatty acid uptake system
- Fatty acid esterification and TAG synthesis
- Lipid transfer between lipid droplets and the ER
- Regulation of lipolysis and lipid mobilization
- Action of lipases (ATGL, HSL and MGL)
- Hormone sensitive lipase (HSL)
- HSL and ATGL expression
- HSL and ATGL in insulin resistant patients
- HSL and ATGL before/after hypocaloric diet
- Perilipin and ABHB5
- Perilipin, HSL translocation
- Perilipin, ABHD5 interactions
- Epinephrine-induced lipolysis
- Alpha2-adrenergic mediated effect
- Distribution of beta and alpha2-receptors
- Signalling pathways in the control of lipolysis
- Visceral and subcutaneous lipolysis
- Beta-adrenergic receptors polymorphisms
- Natriuretic peptides (ANP, BNP, CNP)
- Physiological role of atrial natriuretic peptides
- Natriuretic peptides and lipolysis
- Type A NP receptors (NPR-A) and ANP signalling
- Signalling pathways: cAMP and cGMP cross-talk
- Other lipolytic/antilipolytic pathways
- Diagram of lipolysis human fat cell - summary
- Sum-up physiological approaches
- Epinephrine response normal /obese
- Systemic NEFA release lean/obese
- Hepatic NEFA delivery
- Effects of intravenous atrial natriuretic peptide
- Diagram of in situ microdialysis
- Isoproterenol and microdialysis of sc AT
- ANP effect on lipolysis and blood flow
- Exercise-induced lipid mobilization
- Lipid mobilization and alpha2-blockade
- Lipid mobilization in trained patients
- Lipid mobilization under beta-blockade
- Role of ANP in lipid mobilization
- Lipolysis perspectives
- TAG perspectives and general conclusions
Topics Covered
- Experimental approaches for study of adipose tissue biology
- Lipoprotein lipase and triacylglycerol hydrolysis
- Fatty acid uptake by fat cells
- Triacylglycerol synthesis
- Lipid droplets
- Adipocyte lipases
- Lipid droplet proteins
- Catecholamine-induced lipolysis
- Catecholamine and insulin signalling pathways
- Natriuretic peptides
- Atrial natriuretic peptide and lipolysis
- Lipid mobilization in lean and obese patients
- In situ microdialysis and lipolysis exploration
- Exercise-induced lipid mobilization in lean and obese
- Role of catecholamines
- Alpha2-adrenergic responsiveness and obesity
- Natriuretic peptides and lipid mobilization
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lafontan, M. (2009, January 20). Adipose tissue metabolism and obesity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 23, 2024, from https://doi.org/10.69645/OBRE8097.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Max Lafontan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.